Sfoglia per Autore
JAK2V617F mutation in essential thrombocythemia: Correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients
2009-01-01 Palandri, F.; Ottaviani, E.; Salmi, F.; Catani, L.; Polverelli, N.; Fiacchini, M.; Martinelli, G.; Baccarani, M.; Vianelli, N.
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy
2009-01-01 Palandri, F.; Catani, L.; Testoni, N.; Ottaviani, E.; Polverelli, N.; Fiacchini, M.; De Vivo, A.; Salmi, F.; Lucchesi, A.; Baccarani, M.; Vianelli, N.
Association of essential thrombocythemia and non-Hodgkin lymphoma: A single-centre experience
2009-01-01 Palandri, F.; Derenzini, E.; Ottaviani, E.; Polverelli, N.; Catani, L.; Salmi, F.; Sabattini, E.; Bacci, F.; Zinzani, P. L.; Baccarani, M.; Vianelli, N.
Long-term follow-up of essential thrombocythemia in young adults: Treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients
2010-01-01 Palandri, F.; Polverelli, N.; Ottaviani, E.; Castagnetti, F.; Baccarani, M.; Vianelli, N.
The CD47 pathway is deregulated in human immune thrombocytopenia
2011-01-01 Catani, L.; Sollazzo, D.; Ricci, F.; Polverelli, N.; Palandri, F.; Baccarani, M.; Vianelli, N.; Lemoli, R. M.
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: A retrospective study
2011-01-01 Palandri, F.; Polverelli, N.; Catani, L.; Ottaviani, E.; Baccarani, M.; Vianelli, N.
Very elderly patients with essential thrombocythaemia: Are they a separate category? A monocentric study on 118 patients older than 75years
2012-01-01 Palandri, F.; Polverelli, N.; Catani, L.; Ottaviani, E.; Baccarani, M.; Vianelli, N.
Bleeding in essential thrombocythaemia: A retrospective analysis on 565 patients
2012-01-01 Palandri, F.; Polverelli, N.; Catani, L.; Sollazzo, D.; Ottaviani, E.; Parisi, S.; Baccarani, M.; Vianelli, N.
Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
2012-01-01 Palandri, F.; Polverelli, N.; Lifrieri, F.; Catani, L.; Giannini, M. B.; Baccarani, M.; Vianelli, N.
Splenectomy as a curative treatment for immune thrombocytopenia: A retrospective analysis of 233 patients with a minimum follow up of 10 years
2013-01-01 Vianelli, N.; Palandri, F.; Polverelli, N.; Stasi, R.; Joelsson, J.; Johansson, E.; Ruggeri, M.; Zaja, F.; Cantoni, S.; Catucci, A. E.; Candoni, A.; Morra, E.; Bjorkholm, M.; Baccarani, M.; Rodeghiero, F.
A case report of acute myeloid leukemia and neurofibromatosis 1
2013-01-01 Sartor, C.; Papayannidis, C.; Abbenante, M. C.; Curti, A.; Polverelli, N.; Ottaviani, E.; Iacobucci, I.; Guadagnuolo, V.; Martinelli, G.
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia
2013-01-01 Catani, L.; Sollazzo, D.; Trabanelli, S.; Curti, A.; Evangelisti, C.; Polverelli, N.; Palandri, F.; Baccarani, M.; Vianelli, N.; Lemoli, R. M.
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: Possible role of MPL polymorphisms
2013-01-01 Polverelli, N.; Palandri, F.; Iacobucci, I.; Catani, L.; Martinelli, G.; Vianelli, N.
The choice of second-line therapy in steroid-resistant immune thrombocytopenia: Role of platelet kinetics in a single-centre long-term study
2014-01-01 Palandri, F.; Polverelli, N.; Catani, L.; Sollazzo, D.; Romano, M.; Levorato, M.; Vianelli, N.
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
2014-01-01 Randi, M. L.; Bertozzi, I.; Rumi, E.; Elena, C.; Finazzi, G.; Vianelli, N.; Polverelli, N.; Ruggeri, M.; Vannucchi, A. M.; Antonioli, E.; Lussana, F.; Tieghi, A.; Iurlo, A.; Elli, E.; Ruella, M.; Fabris, F.; Cazzola, M.; Barbui, T.
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
2014-01-01 Ruggeri, M.; Tosetto, A.; Palandri, F.; Polverelli, N.; Mazzucconi, M. G.; Santoro, C.; Gaidano, G.; Lunghi, M.; Zaja, F.; De Stefano, V.; Sartori, R.; Fazi, P.; Rodeghiero, F.
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
2014-01-01 Lussana, F.; Carobbio, A.; Randi, M. L.; Elena, C.; Rumi, E.; Finazzi, G.; Bertozzi, I.; Pieri, L.; Ruggeri, M.; Palandri, F.; Polverelli, N.; Elli, E.; Tieghi, A.; Iurlo, A.; Ruella, M.; Cazzola, M.; Rambaldi, A.; Vannucchi, A. M.; Barbui, T.
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis
2015-01-01 Polverelli, N.; Catani, L.; Sollazzo, D.; Vianelli, N.; Palandri, F.
Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia
2015-01-01 Sollazzo, D.; Polverelli, N.; Palandri, F.; Vianelli, N.; Catani, L.
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
2015-01-01 Polverelli, N.; Catani, L.; Vianelli, N.; Baccarani, M.; Cavo, M.; Palandri, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
JAK2V617F mutation in essential thrombocythemia: Correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients | 1-gen-2009 | Palandri, F.; Ottaviani, E.; Salmi, F.; Catani, L.; Polverelli, N.; Fiacchini, M.; Martinelli, G.; Baccarani, M.; Vianelli, N. | |
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy | 1-gen-2009 | Palandri, F.; Catani, L.; Testoni, N.; Ottaviani, E.; Polverelli, N.; Fiacchini, M.; De Vivo, A.; Salmi, F.; Lucchesi, A.; Baccarani, M.; Vianelli, N. | |
Association of essential thrombocythemia and non-Hodgkin lymphoma: A single-centre experience | 1-gen-2009 | Palandri, F.; Derenzini, E.; Ottaviani, E.; Polverelli, N.; Catani, L.; Salmi, F.; Sabattini, E.; Bacci, F.; Zinzani, P. L.; Baccarani, M.; Vianelli, N. | |
Long-term follow-up of essential thrombocythemia in young adults: Treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients | 1-gen-2010 | Palandri, F.; Polverelli, N.; Ottaviani, E.; Castagnetti, F.; Baccarani, M.; Vianelli, N. | |
The CD47 pathway is deregulated in human immune thrombocytopenia | 1-gen-2011 | Catani, L.; Sollazzo, D.; Ricci, F.; Polverelli, N.; Palandri, F.; Baccarani, M.; Vianelli, N.; Lemoli, R. M. | |
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: A retrospective study | 1-gen-2011 | Palandri, F.; Polverelli, N.; Catani, L.; Ottaviani, E.; Baccarani, M.; Vianelli, N. | |
Very elderly patients with essential thrombocythaemia: Are they a separate category? A monocentric study on 118 patients older than 75years | 1-gen-2012 | Palandri, F.; Polverelli, N.; Catani, L.; Ottaviani, E.; Baccarani, M.; Vianelli, N. | |
Bleeding in essential thrombocythaemia: A retrospective analysis on 565 patients | 1-gen-2012 | Palandri, F.; Polverelli, N.; Catani, L.; Sollazzo, D.; Ottaviani, E.; Parisi, S.; Baccarani, M.; Vianelli, N. | |
Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency | 1-gen-2012 | Palandri, F.; Polverelli, N.; Lifrieri, F.; Catani, L.; Giannini, M. B.; Baccarani, M.; Vianelli, N. | |
Splenectomy as a curative treatment for immune thrombocytopenia: A retrospective analysis of 233 patients with a minimum follow up of 10 years | 1-gen-2013 | Vianelli, N.; Palandri, F.; Polverelli, N.; Stasi, R.; Joelsson, J.; Johansson, E.; Ruggeri, M.; Zaja, F.; Cantoni, S.; Catucci, A. E.; Candoni, A.; Morra, E.; Bjorkholm, M.; Baccarani, M.; Rodeghiero, F. | |
A case report of acute myeloid leukemia and neurofibromatosis 1 | 1-gen-2013 | Sartor, C.; Papayannidis, C.; Abbenante, M. C.; Curti, A.; Polverelli, N.; Ottaviani, E.; Iacobucci, I.; Guadagnuolo, V.; Martinelli, G. | |
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia | 1-gen-2013 | Catani, L.; Sollazzo, D.; Trabanelli, S.; Curti, A.; Evangelisti, C.; Polverelli, N.; Palandri, F.; Baccarani, M.; Vianelli, N.; Lemoli, R. M. | |
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: Possible role of MPL polymorphisms | 1-gen-2013 | Polverelli, N.; Palandri, F.; Iacobucci, I.; Catani, L.; Martinelli, G.; Vianelli, N. | |
The choice of second-line therapy in steroid-resistant immune thrombocytopenia: Role of platelet kinetics in a single-centre long-term study | 1-gen-2014 | Palandri, F.; Polverelli, N.; Catani, L.; Sollazzo, D.; Romano, M.; Levorato, M.; Vianelli, N. | |
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia | 1-gen-2014 | Randi, M. L.; Bertozzi, I.; Rumi, E.; Elena, C.; Finazzi, G.; Vianelli, N.; Polverelli, N.; Ruggeri, M.; Vannucchi, A. M.; Antonioli, E.; Lussana, F.; Tieghi, A.; Iurlo, A.; Elli, E.; Ruella, M.; Fabris, F.; Cazzola, M.; Barbui, T. | |
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors | 1-gen-2014 | Ruggeri, M.; Tosetto, A.; Palandri, F.; Polverelli, N.; Mazzucconi, M. G.; Santoro, C.; Gaidano, G.; Lunghi, M.; Zaja, F.; De Stefano, V.; Sartori, R.; Fazi, P.; Rodeghiero, F. | |
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera | 1-gen-2014 | Lussana, F.; Carobbio, A.; Randi, M. L.; Elena, C.; Rumi, E.; Finazzi, G.; Bertozzi, I.; Pieri, L.; Ruggeri, M.; Palandri, F.; Polverelli, N.; Elli, E.; Tieghi, A.; Iurlo, A.; Ruella, M.; Cazzola, M.; Rambaldi, A.; Vannucchi, A. M.; Barbui, T. | |
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis | 1-gen-2015 | Polverelli, N.; Catani, L.; Sollazzo, D.; Vianelli, N.; Palandri, F. | |
Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia | 1-gen-2015 | Sollazzo, D.; Polverelli, N.; Palandri, F.; Vianelli, N.; Catani, L. | |
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms | 1-gen-2015 | Polverelli, N.; Catani, L.; Vianelli, N.; Baccarani, M.; Cavo, M.; Palandri, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile